Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Aug;38(8):1544-50.
doi: 10.2337/dc14-2775. Epub 2015 May 13.

Improving Adiponectin Levels in Individuals With Diabetes and Obesity: Insights From Look AHEAD

L Maria Belalcazar  1 , Wei Lang  2 , Steven M Haffner  3 , Dawn C Schwenke  4 , Andrea Kriska  5 , Ashok Balasubramanyam  6 , Ron C Hoogeveen  6 , F Xavier Pi-Sunyer  7 , Russell P Tracy  8 , Christie M Ballantyne  9 ; Look AHEAD (Action for Health in Diabetes) Research Group
Collaborators, Affiliations
Randomized Controlled Trial

Improving Adiponectin Levels in Individuals With Diabetes and Obesity: Insights From Look AHEAD

L Maria Belalcazar et al. Diabetes Care. 2015 Aug.

Abstract

Objective: This study investigated whether fitness changes resulting from lifestyle interventions for weight loss may independently contribute to the improvement of low adiponectin levels in obese individuals with diabetes.

Research design and methods: Look AHEAD (Action for Health in Diabetes) randomized overweight/obese individuals with type 2 diabetes to intensive lifestyle intervention (ILI) for weight loss or to diabetes support and education (DSE). Total and high-molecular weight adiponectin (adiponectins), weight, and cardiorespiratory fitness (submaximal exercise stress test) were measured in 1,397 participants at baseline and at 1 year, when ILI was most intense. Regression analyses examined the associations of 1-year weight and fitness changes with change in adiponectins.

Results: ILI resulted in greater improvements in weight, fitness, and adiponectins at 1 year compared with DSE (P < 0.0001). Weight loss and improved fitness were each associated with changes in adiponectins in men and women (P < 0.001 for all), after adjusting for baseline adiponectins, demographics, clinical variables, and treatment arm. Weight loss contributed an additional 4-5% to the variance of change in adiponectins than did increased fitness in men; in women, the contributions of improved fitness (1% greater) and of weight loss were similar. When weight and fitness changes were both accounted for, weight loss in men and increased fitness in women retained their strong associations (P < 0.0001) with adiponectin change.

Conclusions: Improvements in fitness and weight with ILI were favorably but distinctly associated with changes in adiponectin levels in overweight/obese men and women with diabetes. Future studies need to investigate whether sex-specific biological determinants contribute to the observed associations.

Trial registration: ClinicalTrials.gov NCT00017953.

PubMed Disclaimer

References

    1. Yamauchi T, Kamon J, Waki H, et al. . The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941–946 - PubMed
    1. Cnop M, Havel PJ, Utzschneider KM, et al. . Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003;46:459–469 - PubMed
    1. Basu R, Pajvani UB, Rizza RA, Scherer PE. Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects. Diabetes 2007;56:2174–2177 - PubMed
    1. Kim JY, van de Wall E, Laplante M, et al. . Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 2007;117:2621–2637 - PMC - PubMed
    1. Cook JR, Semple RK. Hypoadiponectinemia—cause or consequence of human “insulin resistance”? J Clin Endocrinol Metab 2010;95:1544–1554 - PubMed

Publication types

Associated data